TWIST1 and breast carcinoma: These results also suggest that the blockade of TWIST1-upregulated PD-L1 function in breast cancer cells may help to prevent the immune escape of breast cancer cells and that TWIST1-expressing breast cancer cells may be sensitive to ICI-based immunotherapies.